Enhertu 100 mg Injection is used to treat HER2-positive metastatic breast cancer and gastric cancer. These cancers have high levels of the protein called HER2, which promotes cancer cell growth. It binds to HER2 proteins and delivers chemotherapy directly to cancer cells, destroying them while sparing healthy cells.
A doctor or a nurse administers Enhertu 100mg Injection as an intravenous (IV) infusion, typically every three weeks. Sticking to this schedule is crucial to allow the medication to work effectively, as consistent dosing helps keep cancer cell growth in check. Make sure to attend all scheduled appointments and follow any additional advice from the doctor. Drink plenty of water, stay hydrated, and eat a balanced diet to help the body handle the treatment’s effects.
Enhertu 100 mg Injection
- Treatment of Stomach cancer
- Treatment of Metastatic breast cancer
